Organization Overview
Alternative names
acetylcysteine (mucomyst) (4 trials)
albumin (Human) (Plasbumin) (18 trials)
bifidobacterium breve (1 trial)
bifidobacterium infantis (1 trial)
bifidobacterium longum (1 trial)
branched chain amino acids (2 trials)
bromocriptine (parlodel) (1 trial)
carvedilol (coreg) (10 trials)
dabigatran (pradaxa) (1 trial)
diclofenac (voltaren) (1 trial)
enoxaparin (lovenox) (1 trial)
entecavir (baraclude) (3 trials)
erythromycin (ilosone) (1 trial)
ethambutol (myambutol) (1 trial)
human fecal microbiota (Reybota) (10 trials)
imipenem (primaxin) (2 trials)
indomethacin (indocin) (1 trial)
insulin human (humulin) (1 trial)
interferon alpha-2b (Intron-A) (2 trials)
isoniazid (nydrazid) (1 trial)
ivabradine (corlanor) (1 trial)
lactobacillus bulgaricus (1 trial)
lactobacillus paracasei (1 trial)
lactobacillus plantarum (1 trial)
lactulose (cephulac) (6 trials)
lenvatinib (lenvima) (1 trial)
levofloxacin (levaquin) (1 trial)
lidocaine (xylocaine) (1 trial)
mebendazole (vermox) (1 trial)
midodrine (proamatine) (9 trials)
norepinephrine (levophed) (4 trials)
norfloxacin (noroxin) (1 trial)
phytonadione (konakion) (1 trial)
piperacillin (pipracil) (1 trial)
prednisolone (hydeltra) (1 trial)
prednisone (meticorten) (1 trial)
propranolol (inderal) (1 trial)
ribavirin (virazole) (1 trial)
rifabutin (mycobutin) (1 trial)
rifaximin (xifaxan) (5 trials)
Acute-On-Chronic Liver Failure (Phase 3)
End Stage Liver Disease (Phase 3)
Fatty Liver (Phase 3)
Fibrosis (Phase 4)
Hepatic Insufficiency (Phase 3)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis, Alcoholic (Phase 3)
Liver Cirrhosis (Phase 4)
Liver Diseases (Phase 3)
Liver Failure (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 3)
Postoperative Complications (Phase 4)
Shock (Phase 4)
Shock, Septic (Phase 4)
Vasoplegia (Phase 4)